Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
Researchers Develop Robotic Sensory Cilia that Detect Airway Diseases
The system enables detection and personalized care for diseases like Cystic Fibrosis, Chronic Obstructive Pulmonary Diseases, and lung cancer.
Lung Cancer
Latest
AI-Powered Digital Pathology Platform Aids Lung Cancer Diagnosis
A new AI-driven digital pathology platform enables fully automated, rapid, and accurate analysis of lung cancer tissue.
DELFI Collaborates with Hospital System to Improve Lung Cancer Screening
OSF HealthCare will use DELFI’s FirstLook Lung blood test to enhance lung cancer screening rates and early detection efforts.
Read More
CAP Publishes Guideline for PD-L1 Testing of Lung Cancer Patients
CAP developed recommendations for testing immunotherapy biomarkers, such as PD-L1 and TM), in patients with NSCLC.
Read More
Nucleix’s New Assay May Differentiate Small Cell Lung Cancer Subtypes
Nucleix will present data that demonstrates the potential of a PCR assay to accurately differentiate between small cell lung cancer subtypes.Â
Read More
Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test
The test guides first-line treatment selection by identifying individuals with the highest likelihood of benefit from PD-1/PD-L1 inhibitors
Read More
Noninvasive Testing Key to Id’ing Lung Cancer
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read More
New Epigenomic Technology Platform Predicts Immunotherapy Response in NSCLC Patients
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read More
New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access
ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.Â
Read More
New Sensor Technology May Enable Early Lung Cancer Detection
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Read More
Freenome Initiates Clinical Study of Blood Test for Early Lung Cancer Screening
Freenome’s PROACT LUNG study is intended to validate the clinical performance of its blood test for lung cancer screening.Â
Read More
DELFI Diagnostics Supports Legislation for CMS to Review New Lung Cancer Liquid Biopsies
DELFI Diagnostics is supporting the recently introduced Lung Cancer Screening and Prevention Act (H.R. 6693).
Read More
Liquid Biopsy Predicts Immunotherapy Response, Toxicity in Advanced Lung Cancer Patients
Liquid biopsies could predict which lung cancer patients are responding to immunotherapies or may develop immune-related side effects.
Read More
Veracyte’s Nasal Swab Test Gets Clinical Validation for Lung Cancer Risk Assessment
Clinical validation data shows that Veracyte’s Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.
Read More
OncoHost Develops Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients
OncoHost developed a novel computational model for predicting significant immune-related adverse events in NSCLC patients.
Read More
Personalis’ MRD Assay Detects ctDNA in Lung Cancer Patients Earlier
NeXT Personal ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients
Read More
Thermo Fisher and Boehringer Ingelheim Sign CDx Agreement to Select NSCLC Patients for Targeted Therapy
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.
Read More